|
|
||||||||
AJP - Cell Physiology, Vol 259, Issue 6 C897-C903, Copyright © 1990 by American Physiological Society
ARTICLES |
P. P. Sokol, L. C. Capodagli, M. Dixon, P. D. Holohan, C. R. Ross, R. Coulson and D. B. Jones
Department of Pharmacology, State University of New York, Syracuse 13210.
The capability of cyclosporin to produce direct injury to primary proximal tubular renal cells was studied. These cells, when grown on Millicell inserts, retain the functional polarity of the proximal tubule, i.e., generate a transepithelial pH gradient (apical compartment acidic) that is reversibly blocked by amiloride addition only if it is added to the apical compartment. Administration of ouabain to the basal compartment also blocks the generation of the transepithelial pH gradient. Additionally, the cells were more responsive to parathyroid hormone (PTH), a proximal tubule characteristic, than to arginine vasopressin (AVP), a distal tubule characteristic. The following substances were tested for their effect on the capacity of these cells to generate a pH gradient: Sandimmune, the commercial form of cyclosporin A; the free form of the drug; Cremophor EL, the vehicle used in the commercial preparation; and ethanol, the vehicle used to dissolve the free form. Sandimmune, at 25-50 microM, inhibited the generation of the pH gradient within 24 h. Surprisingly, Cremophor also blocked the development of a pH gradient, although somewhat less effectively. In contrast, 10 microM cyclosporin, regardless of the form tested, had no effect for up to 96 h. These findings show that cyclosporin, in the form of Sandimmune, has a direct toxic effect on these cells; they also suggest that the vehicle, Cremophor, may contribute to the well-established nephrotoxicity of cyclosporin A.
This article has been cited by other articles:
![]() |
D. W. Johnson, H. J. Saunders, F. J. Johnson, S. O. Huq, M. J. Field, and C. A. Pollock Cyclosporin Exerts a Direct Fibrogenic Effect on Human Tubulointerstitial Cells: Roles of Insulin-Like Growth Factor I, Transforming Growth Factor beta 1, and Platelet-Derived Growth Factor J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 535 - 542. [Abstract] [Full Text] |
||||
![]() |
D. W. Johnson, H. J. Saunders, M. J. Field, and C. A. Pollock In vitro effects of simvastatin on tubulointerstitial cells in a human model of cyclosporin nephrotoxicity Am J Physiol Renal Physiol, March 1, 1999; 276(3): F467 - F475. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |